Task Began December 20, 2011 05:31 AM
Explore references by research topic: Besifloxacin Candidates Selected (ID 1)
95 references were found containing the concept "Besifloxacin".
Answer Type: Answers
Result Count: 95
Refine by language (ID 2) Languages:Chinese
From ID: 1
Answer Type: Answers
Result Count: 4
Detailed display
Type: Preparation and application of natamycin ophthalmic composition for treating bacterial and fungal infection of eye
4. Preparation and application of natamycin ophthalmic composition for treating bacterial and fungal infection of eye
By: Ling, Peixue; He, Yanli; Bai, Ruowan; Li, Yongchun; Wan, Xiuyu; Zhang, Qing; Pan, Jifei; Rong, Xiaohua Assignee: Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd., Peop. Rep. China
Patent Information: Oct 08, 2008
,
CN 101278905,
AApplication: May 13, 2008
,
CN 2008-10016213Priority: May 13, 2008
,
CN 2008-10016213Source: Faming Zhuanli Shenqing
,
10pp.,
Patent,
2008,
CODEN: CNXXEVAccession Number: 2008:1231656
,
CAN 149:478621,
CAPLUSLanguage: Chinese
Abstract
The title ophthalmic compn. comprises natamycin, antimicrobial agent, and eye-use medical adjuvant. The antimicrobial agent is selected from one or more of tobramycin, neomycin, ofloxacin, levofloxacin, ciprofloxacin, norfloxacin,
gatifloxacin, moxifloxacin, besifloxacin, and their salts. The medical adjuvant is selected from buffer, osmotic pressure regulator, antiseptic, suspension aid, antioxidant, and complexing agent. The prepn. method comprises dissolving natamycin in basic soln., adding acidic soln. to ppt. natamycin, processing into granules, and processing into eye drop with antimicrobial agent and medical adjuvant. The ophthalmic compn. can be used for treating bacterial and fungal infection of eye, and reducing adverse effects such as taboos, irritation, and allergy.
Patent Information
Patent No. Kind Date Application No. Date
CN 101278905 A Oct 08, 2008 CN 2008-10016213 May 13, 2008 Priority Application CN 2008-10016213 May 13, 2008 Indexing Pharmaceuticals (Section 63-6) Section cross-reference(s): 1 Concepts
Quaternary ammonium compounds
alkylbenzyldimethyl, bromides; prepn. and application of natamycin ophthalmic compn. for treating bacterial and fungal infection of eye
Therapeutic use; Biological study; Uses Quaternary ammonium compounds
alkylbenzyldimethyl, chlorides; prepn. and application of natamycin ophthalmic compn. for treating bacterial and fungal infection of eye
Therapeutic use; Biological study; Uses Infection
eye infection; prepn. and application of natamycin ophthalmic compn. for treating bacterial and fungal infection of eye Eye disease
Microorganism
infection; prepn. and application of natamycin ophthalmic compn. for treating bacterial and fungal infection of eye Ophthalmic drug delivery systems
Pharmaceutical solutions
ophthalmic solns.; prepn. and application of natamycin ophthalmic compn. for treating bacterial and fungal infection of eye
Anti-infective agents Antibacterial agents Antioxidants Bacterial infection Buffers Chelating agents Dissolution Fungicides Human Mammalia
Ophthalmic drug delivery systems Pharmaceutical microparticles Precipitation(chemical) Preservatives
prepn. and application of natamycin ophthalmic compn. for treating bacterial and fungal infection of eye Osmotic pressure
regulator; prepn. and application of natamycin ophthalmic compn. for treating bacterial and fungal infection of eye Drugs
veterinary; prepn. and application of natamycin ophthalmic compn. for treating bacterial and fungal infection of eye Substances
77-92-9 Citric acid, biological studies 14265-44-2 Phosphate, biological studies
buffer; prepn. and application of natamycin ophthalmic compn. for treating bacterial and fungal infection of eye
Therapeutic use; Biological study; Uses 1404-04-2 Neomycin 7681-93-8 Natamycin 32986-56-4 Tobramycin 70458-96-7 Norfloxacin 82419-36-1 Ofloxacin 85721-33-1 Ciprofloxacin 100986-85-4 Levofloxacin 112811-59-3 Gatifloxacin 141388-76-3 Besifloxacin
SciFinder®
Page 3
Copyright © 2011 American Chemical Society (ACS). All Rights Reserved.
Absolute stereochemistry., Rotation (+). 151096-09-2 Moxifloxacin
prepn. and application of natamycin ophthalmic compn. for treating bacterial and fungal infection of eye
Biological study, unclassified; Pharmacological activity; Pharmacokinetics; Therapeutic use; Biological study; Uses 1310-73-2 Sodium hydroxide, uses
7647-01-0 Hydrochloric acid, uses
prepn. and application of natamycin ophthalmic compn. for treating bacterial and fungal infection of eye
Other use, unclassified; Uses 56-81-5 Glycerol, biological studies 60-00-4 Edta, biological studies 68-04-2 Sodium citrate
7558-79-4
7558-80-7 Sodium dihydrogen phosphate 7647-14-5 Sodium chloride, biological studies 7757-83-7 Sodium sulfite
9003-39-8 Pvp
9004-65-3 Hypromellose 9067-32-7 Sodium hyaluronate
prepn. and application of natamycin ophthalmic compn. for treating bacterial and fungal infection of eye
Therapeutic use; Biological study; Uses Supplementary Terms
natamycin; ophthalmic; compn; bacteria; fungus; infection; eye; Tags
0 Tags Comments 0 Comments
